Agios

$36.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.21 (-3.21%) As of 3:25 PM EDT today
-$1.21 (-3.21%) Today

Why Robinhood?

You can buy or sell Agios and other stocks, options, ETFs, and crypto commission-free!

About AGIO

Agios Pharmaceuticals, Inc. Common Stock, also called Agios, is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. Read More It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Employees
482
Headquarters
Cambridge, Massachusetts
Founded
2007
Market Cap
2.22B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
706.79K
High Today
$38.03
Low Today
$36.25
Open Price
$37.64
Volume
342.68K
52 Week High
$79.17
52 Week Low
$33.17

Collections

AGIO Earnings

-$1.87
-$1.64
-$1.42
-$1.19
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 31, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.